Adjuvant Therapy in Resected Melanoma
- PMID: 29446283
- DOI: 10.1056/NEJMc1716071
Adjuvant Therapy in Resected Melanoma
Comment in
-
Adjuvant Therapy in Resected Melanoma.N Engl J Med. 2018 Feb 15;378(7):679-680. doi: 10.1056/NEJMc1716071. N Engl J Med. 2018. PMID: 29443674 No abstract available.
-
More on Adjuvant Therapy in Resected Melanoma.N Engl J Med. 2018 Apr 26;378(17):1656-1657. doi: 10.1056/NEJMc1803342. N Engl J Med. 2018. PMID: 29694823 No abstract available.
Comment on
-
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.N Engl J Med. 2017 Nov 9;377(19):1813-1823. doi: 10.1056/NEJMoa1708539. Epub 2017 Sep 10. N Engl J Med. 2017. PMID: 28891408 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical